在认知障碍中的纯能受体
Peter Illes1, Henning Ulrich2, Jiang-Fan Chen3
1School of Acupuncture and Tuina, Chengdu University of Traditonal Chinese Medicine, Chengdu 610075, China; Rudolf Boehm Institute for Pharmacology and Toxicology, University of Leipzig, 04107 Leipzig, Germany; International Joint Research Center for Purinergic Signaling, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
纯原体受体,如P2X7和A2AR,与神经退行性和精神疾病的认知衰退有关. 针对这些受体的小分子对抗剂对未来的治疗方法来对抗认知恶化充满希望.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 纯能受体 (ATP/ADP,UTP/UDP,腺敏感) 影响认知功能.
- 神经退行性疾病释放ATP,它降解为腺,导致大脑损伤.
研究的目的:
- 研究纯能受体,特别是P2X7和A2AR在与神经和精神疾病相关的认知障碍中的作用.
- 探索这些受体的小分子抗剂的治疗潜力.
主要方法:
- 利用神经退行性疾病 (阿尔茨海默病,帕金森病,亨廷顿病) 和精神疾病的动物模型.
- 研究了P2X7和A2AR激活和对抗对认知功能的影响.
- 针对相关的纯能受体,研究了淘汰赛小鼠模型.
主要成果:
- P2X7和A2AR激活有助于神经退行性疾病中的叠加损伤.
- 在动物模型中,P2X7和A2AR的对手可以预防或减轻认知缺陷.
- 有证据表明P2X7和A2AR参与了诸如MDD之类的精神疾病.
结论:
- purinergic受体对抗剂为各种神经和精神疾病的认知衰退提供了潜在的治疗策略.
- 针对P2X7和A2AR可能会为未来的药物干预提供针对认知恶化的药物干预.
更多相关视频
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
05:17BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
Published on: May 26, 2023
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
G-protein Coupled Receptors
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Drugs Affecting Neurotransmitter Release or Uptake
Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
